Group 1 - The company disclosed its main operating data for the first half of 2025, including production, sales volume, and revenue for key products [1] - Chlorobenzene products had a production volume of 129,943.62 tons, sales volume of 127,172.51 tons, and revenue of 75,723.26 million yuan [1] - The total production volume for caustic soda products was 1,173,138.18 tons, with a sales volume of 390,802.41 tons and revenue of 59,837.47 million yuan [1] Group 2 - The average price of chlorobenzene products decreased by 13% to 6,868.34 yuan per ton compared to the previous period [1] - The average price of caustic soda products decreased by 5% to 1,611.59 yuan per ton [1] - The average price of resin products increased by 8% to 11,635.39 yuan per ton [1] Group 3 - The average price of rubber antioxidants decreased by 11% to 18,978.35 yuan per ton [1] - The average price of benzene, a key raw material, decreased by 26% to 8,187.00 yuan per ton [1] - The average price of coal decreased by 21% to 792.00 yuan per ton [1]

债券代码：241598 债券简称：24 中化 K1 中化国际（控股）股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ? 拟聘任的会计师事务所名称：毕马威华振会计师事务所（特殊普通合伙） （以下简称"毕马威华振"） 证券代码：600500 证券简称：中化国际 编号：2025-050 债券代码：138949 债券简称：23 中化 K1 毕马威华振总所位于北京，注册地址为北京市东城区东长安街 1 号东方广场 东 2 座办公楼 8 层。 毕马威华振的首席合伙人邹俊，中国国籍，具有中国注册会计师资格。 于 2024 年 12 月 31 日，毕马威华振有合伙人 241 人，注册会计师 1,309 人， 其中签署过证券服务业务审计报告的注册会计师超过 300 人。 毕马威华振 2024 年经审计的业务收入总额超过人民币 41 亿元，其中审计业 务收入超过人民币 40 亿元（包括境内法定证券服务业务收入超过人民币 9 亿元， 其他证券服务业务收入约人民币 10 亿元，证券服务业务 ...

Core Viewpoint - The report evaluates the financial risk assessment of Sinochem International (Holding) Co., Ltd. regarding its subsidiary, Sinochem Group Finance Co., Ltd., highlighting its financial stability and compliance with regulatory requirements [1][17]. Group 1: Company Overview - Sinochem Group Finance Co., Ltd. was established in June 2008 and is approved by the China Banking Regulatory Commission, with a registered capital of 600 million yuan [1][2]. - The company is wholly owned by Sinochem Holdings Corporation, with a shareholding structure comprising Sinochem Holdings (37%), Sinochem Co., Ltd. (35%), and Sinochem Capital Co., Ltd. (28%) [2]. Group 2: Financial Performance - As of June 30, 2025, the total assets of Sinochem Finance were 706.04 billion yuan, with total equity of 130.69 billion yuan [16]. - The company reported deposits from member units amounting to 571.68 billion yuan and issued loans totaling 472.47 billion yuan during the same period [16]. - For the first half of 2025, the company achieved interest income of 6.35 billion yuan and a net profit of 0.93 billion yuan [16]. Group 3: Risk Management and Internal Control - Sinochem Finance has established a comprehensive internal control system, including a risk management department and various operational procedures to mitigate risks associated with its financial activities [3][4]. - The company adheres to strict funding management principles, prioritizing safety, liquidity, and profitability in its operations [5][6]. - The internal control evaluation indicates that the company effectively manages risks related to fund circulation and credit operations, maintaining a reasonable level of overall risk [15]. Group 4: Regulatory Compliance - As of June 30, 2025, Sinochem Finance met all regulatory requirements, including a capital adequacy ratio of 12.33% and a liquidity ratio of 61.45%, both exceeding the minimum standards [16]. - The company has not faced any significant operational risks or regulatory penalties, demonstrating its compliance with the relevant financial regulations [17].

中化国际（控股）股份有限公司 | 证券代码：600500 | 证券简称：中化国际 | | | 编号：2025-050 | | --- | --- | --- | --- | --- | | 债券代码：138949 | 债券简称：23 | 中化 | K1 | | | 债券代码：241598 | 债券简称：24 | 中化 | K1 | | 关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 拟聘任的会计师事务所名称：毕马威华振会计师事务所（特殊普通合伙） （以下简称"毕马威华振"） 中化国际（控股）股份有限公司（以下简称"公司"）于 2025 年 8 月 27 日 召开了第十届董事会第十次会议，会议审议通过了《关于公司续聘 2025 年度财 务审计和内控审计机构的议案》，同意公司续聘毕马威华振会计师事务所（特殊 普通合伙）为公司 2025 年度财务审计和内控审计机构，并同意将该议案提交公 司股东大会审议，具体情况如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1.基本信息 毕 ...

| 主要产品 | 2024 年 | 1-6 | 月平 | 2025 年 1-6 | | 月平 | 变动比率 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 均价格（元/吨） | | | 均价格（元/吨） | | | | | 氯苯产品 | | 6,868.34 | | | 5,954.37 | | -13% | | 氯碱产品 | | 1,611.59 | | | 1,531.14 | | -5% | | 树脂产品 | | 11,635.39 | | | 12,584.80 | | 8% | | 橡胶防老剂 | | 18,978.35 | | | 16,842.72 | | -11% | 主要产品 2025 年 1-6 月产 量（吨） 2025 年 1-6 月销 量（吨） 2025 年 1-6 月销 售金额（万元） 氯苯产品 129,943.62 127,172.51 75,723.26 氯碱产品 1,173,138.18 390,802.41 59,837.47 树脂产品 164,669.30 144,996.16 182,474.76 橡胶防老剂 ...

中化国际（控股）股份有限公司关于 中化集团财务有限责任公司2025年半年度风险评估报告 根据上交所《上海证券交易所上市公司自律监管指引第5号—交易与关联交 易》的要求，中化国际（控股）股份有限公司（以下简称"中化国际"或"本公 司"）通过查验中化集团财务有限责任公司的《企业法人营业执照》与《金融许 可证》等资料，并审阅了包括资产负债表、利润表、现金流量表等在内的财务公 司的定期财务报告，对其经营资质、业务和风险状况进行了评估，具体情况报告 如下： 一、 中化集团财务有限责任公司基本情况 中化集团财务有限责任公司（以下简称"公司"或"中化财务公司"）系经 原中国银行业监督管理委员会批准，2008 年 5 月取得金融许可证，于 2008 年 6 月 4 日 在 北 京 成 立 的 有 限 责 任 公 司 。 现 公 司 统 一 社 会 信 用 代 码 为 911100007109354688，注册资本 60 亿元；法定代表人为夏宇。 2025 年 6 月 30 日，经国家金融监督管理总局雄安新区监管分局批准，公司 金融许可证机构编码变更为 L0091H313310001，编号变更为 01122074；经河北雄 安 ...

中化国际（控股）股份有限公司 第十届监事会第五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 中化国际（控股）股份有限公司（以下简称"公司"）第十届监事会第五次 会议于2025年8月27日在北京召开。会议应到监事3名，现场实到监事3名，出席 会议监事超过全体监事的半数。会议符合《公司法》《公司章程》及《监事会议 事规则》的有关规定。经认真讨论，会议审议通过以下决议： | 证券代码：600500 | 证券简称：中化国际 | | | 编号：2025-048 | | --- | --- | --- | --- | --- | | 债券代码：138949 | 债券简称：23 | 中化 | K1 | | | 债券代码：241598 | 债券简称：24 | 中化 | K1 | | 特此公告。 中化国际（控股）股份有限公司 2025 年 8 月 28 日 - 2 - 三、参与2025年半年度报告编制和审议的人员严格遵守保密规定， 无损害 公司和投资者利益的行为发生。 - 1 - 一、公司2025年半年度报告的编制和审议 ...

| 证券代码：600500 | 证券简称：中化国际 | 编号：2025-047 | | --- | --- | --- | | 债券代码：138949 | 债券简称：23中化K1 | | | 债券代码：241598 | 债券简称：24中化K1 | | 中化国际（控股）股份有限公司 第十届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 中化国际（控股）股份有限公司（以下简称"公司"）第十届董事会第十次 会议于 2025 年 8 月 27 日在北京召开。会议应到董事 7 名，现场会议实到董事 4 名，委托出席董事 3 名。其中董事庞小琳先生因工作原因无法出席，委托董 事长张学工先生代为出席并行使表决权；董事刘文先生因工作原因无法出席， 委托董事胡斌先生代为出席并行使表决权；独立董事钱明星先生因工作原因无 法出席，委托独立董事程凤朝先生代为出席并行使表决权，出席会议董事超过 全体董事的半数。会议符合《公司法》《公司章程》及《董事会议事规则》的有 关规定。会议由张学工董事长主持，经认真讨论，会议审议通过 ...

| 公司代码：600500 | 中化国际（控股）股份有限公司2025 年半年度报告摘要 | | | | --- | --- | --- | --- | | | 公司简称：中化国际 | | | | | 中化国际（控股）股份有限公司 | | | | | 中化国际（控股）股份有限公司2025 年半年度报告摘要 | | | | | 第一节 重要提示 | | | | 展规划，投资者应当到 | | http://www.sse.com.cn/网站仔细阅读半年度报告全文。 | | | 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 | | | | | 未出席董事职务 | 未出席董事姓名 | 未出席董事的原因说明 | 被委 | | 托人姓名 | | | | | 董事 | 庞小琳 | 工作原因 | 张学工 | | 董事 | 刘文 | 工作原因 | 胡斌 | | 独立董事 | 钱明星 | 工作原因 | 程凤朝 | | 无 | | | | | | 第二节 公司基本情况 | | | | | 公司股票简况 | | | | 股票种类 | 股票上市交易所 股票简称 | | 股票代码 变更前股 | | 票简称 | ...

Core Viewpoint - The report highlights the financial performance of Sinochem International Corporation for the first half of 2025, indicating a decline in revenue and net profit, while emphasizing operational efficiency and cost control measures in response to challenging market conditions [1][2]. Financial Performance - The total revenue for the first half of 2025 was approximately CNY 24.35 billion, a decrease of 5.83% compared to CNY 25.86 billion in the same period last year [2]. - The total profit for the period was a loss of approximately CNY 1.02 billion, compared to a profit of CNY 2.19 million in the previous year [2]. - The net profit attributable to shareholders was approximately -CNY 885.84 million, down from a profit of CNY 12.32 million in the previous year [2]. - The net cash flow from operating activities increased by 68.81% to approximately CNY 933.47 million, compared to CNY 552.98 million in the previous year [2]. Business Segments - The basic raw materials and intermediates segment saw a 34% increase in sales volume, despite a challenging pricing environment [9]. - The high-performance materials segment experienced a 15% decrease in sales volume, with a focus on cost control leading to a 5% increase in gross margin [10]. - The polymer additives business faced a 9% decline in product prices, with a 7% decrease in sales volume, but managed to improve gross margin by 1% [10]. Operational Strategies - The company implemented strict cost control measures, resulting in a 6% reduction in sales expenses and a 5% reduction in management expenses compared to the previous year [9]. - The company emphasized operational efficiency, achieving a 4% improvement in working capital turnover [9]. - The company maintained high operational rates for key production facilities, with core units operating at over 95% capacity [9]. Market Environment - The chemical industry faced significant challenges due to fluctuating commodity prices and geopolitical events, impacting overall market demand and pricing [9][11]. - The company is actively exploring new markets and enhancing its product offerings to adapt to changing market conditions [11]. Innovation and Sustainability - The company is committed to sustainable development and has implemented advanced HSE (Health, Safety, and Environment) management practices to enhance operational safety and environmental protection [12][13]. - The company has established a comprehensive R&D framework to drive innovation and improve product quality, with a focus on customer solutions [14]. Financial Health - As of mid-2025, the company had a total bank credit line of CNY 84.8 billion, with a competitive financing cost of 2.43% [15]. - The company successfully issued bonds totaling CNY 35 billion during the first half of the year, demonstrating strong market confidence [15].